Added to YB: 2018-01-03
Pitch date: 2018-01-03
NXTM [bullish]
NxStage Medical, Inc.
+22.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
NxStage Medical, Inc., a medical technology company, develops, manufactures and markets products for the treatment of end-stage renal disease (ESRD) and acute kidney failure.
Market Cap
$2.0B
Pitch Price
$24.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-362.22
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
NXSTAGE MEDICAL INC NXTM
A summary for this pitch has not been created yet.
Read full article (0 min)